Impact of Low-density Lipoprotein Cholesterol Levels on Outcomes in Nonvalvular Atrial Fibrillation: Results from the China Atrial Fibrillation Registry Study

Zhi-Zhao Li; Xin Du; Nian Liu; Xue-yuan Guo; Chao Jiang; Liu He; Shi-jun Xia; Wei Wang; Ri-bo Tang; San-shuai Chang; Rong-hui Yu; De-yong Long; Rong Bai; Cai-hua Sang; Song-nan Li; Jian-zeng Dong; Chang-sheng Ma

doi:10.12659/MSM.934747

14 April 2022 : Database Analysis

Impact of Low-density Lipoprotein Cholesterol Levels on Outcomes in Nonvalvular Atrial Fibrillation: Results from the China Atrial Fibrillation Registry Study

Zhi-Zhao Li^12ABCDEF*, Xin Du^2A, Nian Liu^2A, Xue-yuan Guo^2A, Chao Jiang^2A, Liu He^2C, Shi-jun Xia^2A, Wei Wang^2A, Ri-bo Tang^2A, San-shuai Chang^2A, Rong-hui Yu^2A, De-yong Long^2A, Rong Bai^2A, Cai-hua Sang^2A, Song-nan Li^2A, Jian-zeng Dong^2A, Chang-sheng Ma^2A

DOI: 10.12659/MSM.934747

Med Sci Monit 2022; 28:e934747

Authors information Article notes Copyright and License information

Background Material and Methods Results Discussion Conclusions References

Related articles Order reprints Share article Share by email

View HTML version

Figure 2 (A) Stroke/thromboembolism and cardiovascular mortality-free survival rate by quartile of LDL-C with CHA2DS2-VASc score <2. (B) Stroke/thromboembolism and cardiovascular mortality-free survival rate by quartile of LDL-C with CHA2DS2-VASc score ≥2.

Back to the Article

Impact of Low-density Lipoprotein Cholesterol Levels on Outcomes in Nonvalvular Atrial Fibrillation: Results from the China Atrial Fibrillation Registry Study

Your Privacy